Toggle navigation
Browse
Home
Researchers
Research Departments
Publications
About/Support
The safety and efficacy of immune checkpoint inhibitor rechallenge after immune-related adverse events in stage IV NSCLC patients.
Meeting Abstract
Overview
Research
Additional Document Info
View All
Overview
cited authors
Guo, Mengni; Vanderwalde, Ari M.; Yu, Xinhua; Vidal, Gregory A.; Tian, Gary G.
Publication Date
June 1, 2022
webpage
Web of Science
published in
JOURNAL OF CLINICAL ONCOLOGY
Journal
Research
category
ONCOLOGY
Web of Science Category
Additional Document Info
volume
40
issue
16